Nontherapeutic Human Experimentation in healthy volunteers
Showing 9976 - 10000 of >10,000
Covid19 Trial in Hong Kong (SARS-CoV-2 DNA Vaccine, Matching )
Recruiting
- Covid19
- SARS-CoV-2 DNA Vaccine
- Matching placebo
-
Hong Kong, Hong KongHKU Phase 1 Clinical Trials Centre
Jan 26, 2022
Systemic Lupus Erythematosus Trial in Changchun (IL-2)
Completed
- Systemic Lupus Erythematosus
-
Changchun, Changchun/Jilin, ChinaSirui Yang
Aug 16, 2022
Healthy Trial in New Haven (Ritlecitinib 50 mg, Ritlecitinib 200 mg)
Completed
- Healthy
- Ritlecitinib 50 mg
- Ritlecitinib 200 mg
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Feb 4, 2022
COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)
Active, not recruiting
- COVID-19
- Tozinameran - Standard dose
- +3 more
-
Melbourne, Victoria, AustraliaRoyal Children's Hospital
Aug 24, 2022
Smoking, Smoking Behaviors, Tobacco Use Trial in Knoxville (Product A1, Product B, Product C)
Completed
- Smoking
- +3 more
- Product A1
- +9 more
-
Knoxville, TennesseeAMR Knoxville
Jun 23, 2022
Respiratory Tract Dysplasia or Lung Cancer, Head and Neck
Recruiting
- Esophageal Cancer
- +3 more
- immunohistochemistry staining method
- +3 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center at UC Health Sciences Cente
Nov 1, 2022
MSPT Device in Routine Clinical Practice in Swiss Healthcare
Recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome
- MSPT
-
Bern, SwitzerlandInselspital Bern, Ambulantes Neurozentrum
Nov 1, 2022
Rabies Trial in Little Rock (KamRAB - HRIG)
Completed
- Rabies
- KamRAB - HRIG
-
Little Rock, ArkansasACH
Aug 31, 2021
Gastrointestinal Motility Disorder, Dyspepsia Trial (Prucalopride, Placebo)
Completed
- Gastrointestinal Motility Disorder
- Dyspepsia
- Prucalopride
- Placebo
- (no location specified)
Oct 25, 2021
Inflammation, Metabolic Disorder, Hypertriglyceridemia Trial in Bozeman (Aronia juice, Placebo)
Completed
- Inflammation
- +2 more
- Aronia juice
- Placebo
-
Bozeman, MontanaNutrition Research Laboratory
Feb 15, 2022
Fluid Loss Trial in Denver, Columbus (CM-1600)
Not yet recruiting
- Fluid Loss
- CM-1600
-
Denver, Colorado
- +1 more
Jul 14, 2022
Lymphoma, Non-Hodgkin Trial in Worldwide (Standard of Care, JCAR017)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Standard of Care
- JCAR017
-
Phoenix, Arizona
- +78 more
Jan 13, 2023
Healthy Trial in Sacramento (Monosaccharide Powder, Placebo Comparator)
Recruiting
- Healthy
- Monosaccharide Powder
- Placebo Comparator
-
Sacramento, CaliforniaUniversity of California, Davis Medical Center
May 3, 2022
Endothelial Dysfunction, Biochemical Markers Trial in Philadelphia (Electronic Cigarette Aerosol)
Recruiting
- Endothelial Dysfunction
- Biochemical Markers
- Electronic Cigarette Aerosol
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Perelman School of Medicine
Nov 17, 2021
Dietary Supplementation Trial in Riverside (Grape seed extract)
Completed
- Dietary Supplementation
- Grape seed extract
-
Riverside, CaliforniaCalifornia Baptist University
Jul 12, 2023
Cannabis, Psychotic Disorders Trial in West Haven (THC, Placebo)
Completed
- Cannabis
- Psychotic Disorders
- THC
- Placebo
-
West Haven, ConnecticutVA Connecticut Healthcare System
Jan 27, 2022
Bioequivalence Trial in Yaroslavl (Etoricoxib film-coated tablet 120 mg, Arcoxia® film-coated tablet 120 mg)
Not yet recruiting
- Bioequivalence
- Etoricoxib film-coated tablet 120 mg
- Arcoxia® film-coated tablet 120 mg
-
Yaroslavl, Russian FederationPrivate healthcare institution "Clinical Hospital "RZD-Medicine"
Mar 31, 2021
Healthy, Insulin Resistance Trial in New Haven (Ultrasound)
Recruiting
- Healthy
- Insulin Resistance
- Ultrasound
-
New Haven, ConnecticutYale-New Haven Hospital
Mar 11, 2022
Stunting Trial in Jakarta (No Intervention)
Completed
- Stunting
- No Intervention
-
Jakarta, DKI Jakarta, IndonesiaUniversity
Aug 25, 2022
Standardization of Quantitative Muscle Ultrasonographic
Not yet recruiting
- Muscle Disease
- ultrasound
- (no location specified)
Jan 14, 2022
Rotavirus Infection, Rotavirus Vaccines Trial in United States (Rotarix, Pediarix, Hiberix)
Completed
- Rotavirus Infection
- Rotavirus Vaccines
- Rotarix
- +3 more
-
Birmingham, Alabama
- +46 more
Dec 7, 2020
Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma Trial in
Recruiting
- Advanced Head and Neck Squamous Cell Carcinoma
- +14 more
- Laboratory Biomarker Analysis
- +3 more
-
Indianapolis, Indiana
- +4 more
Aug 19, 2022
Shigellosis, Bacillary Dysentery Trial in Leiden (2.5 µg InvaplexAR-Detox, 10 µg InvaplexAR-Detox, 0.1 µg of dmLT)
Not yet recruiting
- Shigellosis
- Bacillary Dysentery
- 2.5 μg InvaplexAR-Detox
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Jul 26, 2023
Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss Trial in United States (CGF166)
Completed
- Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss
-
Kansas City, Kansas
- +3 more
Oct 7, 2021